Carmell Therapeutics Corp

Industry: Biotechnology (See others in industry)

Address:
2403 Sidney Street, Suite 300
Pittsburgh, PA, 15203
Phone: 215-688-6196

Filings

Date Type Incremental Cash Raw Filing
2020-09-25 Amended $2,304,324 SEC link
2020-07-08 New $50,000 SEC link
2019-10-16 New $80,000 SEC link
2019-03-14 Amended $4,034,535 SEC link
2018-07-13 New $1,150,000 SEC link
2018-04-25 Amended $75,000 SEC link
2018-01-10 New $364,160 SEC link
2017-12-06 Amended $1,568,774 SEC link
2017-10-03 New $398,235 SEC link
2017-04-14 Amended $288,101 SEC link
2017-01-09 New $767,474 SEC link
2016-02-05 New $774,853 SEC link
2015-08-04 New $137,233 SEC link
2014-12-30 Amended $252,354 SEC link
2014-11-12 New $303,818 SEC link
2014-06-11 Amended $311,456 SEC link
2013-12-23 New $370,000 SEC link
2012-12-14 New $410,797 SEC link
2011-04-13 New $2,389,228 SEC link

Directors and Executives (Current and Past)

Name Role
David W. Anderson Director
Wendy Di Cicco Director
J. Michael Egan Director
Donna Godward Executive
James Hart Executive
Randolph Hubbell Director, Executive
James F. Jordan Director
Stephanie Kladakis Executive
Paul Kornblith Director, Executive
William Newlin Director, Executive
Richard Upton Director
Alan I. West Director, Executive